{
    "paper_id": "2e69e0b893337eee61cc247e01b16c30321832bd",
    "metadata": {
        "title": "",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Tessitore, N., 331 Textor, S.C., 858 Thalhammer, F., 310 Thomas, D., 6:E25 Thomas, D.B., 5:E23 Thomas, W.J., 926 Thompson, B., 582 Ting, G.O., 1020 Tokuyama, K., 271 Tomford, R.C., 605 Tominaga, Y., 729 Tomita, K., 1287 Tomlanovich, S.L., 362 Tong, G.M.W., 1075 T\u00f6rnroth, T., 960, 1139 Toth, H.L., 5:E22 Toto, R., 617 Toto, R.D., 1200 Trachtman, H., 2:E8 Troidle, L., 350 Tsai, T.J., 2:E6 Tuppin, P., 513 Turney, J.H., 3:E15 Tuttle, K.R., 456",
            "cite_spans": [
                {
                    "start": 113,
                    "end": 147,
                    "text": "Thompson, B., 582 Ting, G.O., 1020",
                    "ref_id": null
                },
                {
                    "start": 148,
                    "end": 219,
                    "text": "Tokuyama, K., 271 Tomford, R.C., 605 Tominaga, Y., 729 Tomita, K., 1287",
                    "ref_id": null
                },
                {
                    "start": 220,
                    "end": 261,
                    "text": "Tomlanovich, S.L., 362 Tong, G.M.W., 1075",
                    "ref_id": null
                },
                {
                    "start": 262,
                    "end": 285,
                    "text": "T\u00f6rnroth, T., 960, 1139",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "Allergic disease, interleukin-4-related gene polymorphisms and, 271-276 Allocation algorithm development, for kidney transplantation, 882-890 Allograft, renal dysfunction, dense deposit disease and, [207] [208] [209] [210] [211] evaluation of, [193] [194] [195] [196] [197] [198] [199] [200] [201] loss, in BKV-associated interstitial nephritis, retransplantation after, 821-825 mortality in elderly ESRD patients and, 1013-1019 multicentric papillary renal carcinoma in, 381-384 preexisting crescentic glomerulonephritis in, 5:E23 survival, residual renal function in preemptive kidney transplantation and, 1275-1282 Allopurinol, for acquired reactive perforating collagenosis in nondiabetic HD patient, 3:E12 Alport's syndrome nephrology core curriculum, 1305-1317 retransplantation after polyoma BK virus-associated allograft loss, 821-825 Aluminum, overload and toxicity in CKD clinical features and therapeutic considerations, S3:108-116 treatment algorithm, S3:116-122 Amino acids in CAPD dialysate, long-term study of, 173-183 in ESRD hemodialysis patients, 1212-1220 Amphotericin B, for mucormycosis peritonitis during longterm PD, 3:E13 Amyloidosis, long-term outcome of kidney transplant, 370-375 Analgesic usage in ESRD, 217-228 kidney function changes in healthy men and, 234-244 for pain in hemodialysis, 1239-1247 renal disease in postphenacetin era and, 385-387 ANCA-positive glomerulonephritis associated with minocycline, E9 recurrence after kidney transplantation, 4:E18 Anderson-Fabry disease, nephrology core curriculum, 1305-1317 Anemia in chronic kidney disease, KEEP program participants and, S4:49-S4:56 heme iron polypeptide in HD patients, 325-330 malnutrition-inflammation complex syndrome in dialysis and, 864-881 management in quotidian hemodialysis, S1:18-23 renal tubular dysfunction in \u2424-thalassemia minor, 1164-1168 Angiotensin-converting enzyme (ACE) inhibitors for atherosclerotic renal artery stenosis, 851-857 with calcium channel blockers for nondiabetic nephropathy, 67-75 for cardiovascular risk reduction in dialysis patients, 1301-1304 progression of renal insufficiency in type 2 diabetes mellitus, 936-942 Animal models of diabetic nephropathy, ruboxistaurin effects in, 456-465 Daily hemodialysis adequacy of, S1:42-48 anemia management, S1:18-23 calcium and phosphate balance in, S1:24-29 conversion to, comorbidity in ESRD and, 1020-1035 nursing issues, S1:56-60 nutritional status and, S1:30-35 operating cost comparisons for, S1:49-55 patient quality of life, S1:36-41 technical considerations, S1:66-70 volume control and blood pressure management in, S1: adequacy of, S1:42-48 anemia management, S1:18-23 calcium and phosphate balance in, S1:24-29 London Daily/Nocturnal Hemodialysis Study, S1:5-12 nursing issues, S1:56-60 nutritional status and, S1:30-35 operating cost comparisons for, S1:49-55 patient monitoring, S1:61-65 patient quality of life, S1:36-41 technical considerations, S1:66-70 volume control and blood pressure management in, S1: ",
            "cite_spans": [
                {
                    "start": 199,
                    "end": 204,
                    "text": "[207]",
                    "ref_id": null
                },
                {
                    "start": 205,
                    "end": 210,
                    "text": "[208]",
                    "ref_id": null
                },
                {
                    "start": 211,
                    "end": 216,
                    "text": "[209]",
                    "ref_id": null
                },
                {
                    "start": 217,
                    "end": 222,
                    "text": "[210]",
                    "ref_id": null
                },
                {
                    "start": 223,
                    "end": 228,
                    "text": "[211]",
                    "ref_id": null
                },
                {
                    "start": 229,
                    "end": 243,
                    "text": "evaluation of,",
                    "ref_id": null
                },
                {
                    "start": 244,
                    "end": 249,
                    "text": "[193]",
                    "ref_id": null
                },
                {
                    "start": 250,
                    "end": 255,
                    "text": "[194]",
                    "ref_id": null
                },
                {
                    "start": 256,
                    "end": 261,
                    "text": "[195]",
                    "ref_id": null
                },
                {
                    "start": 262,
                    "end": 267,
                    "text": "[196]",
                    "ref_id": null
                },
                {
                    "start": 268,
                    "end": 273,
                    "text": "[197]",
                    "ref_id": null
                },
                {
                    "start": 274,
                    "end": 279,
                    "text": "[198]",
                    "ref_id": null
                },
                {
                    "start": 280,
                    "end": 285,
                    "text": "[199]",
                    "ref_id": null
                },
                {
                    "start": 286,
                    "end": 291,
                    "text": "[200]",
                    "ref_id": null
                },
                {
                    "start": 292,
                    "end": 297,
                    "text": "[201]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": ""
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "See Kidney transplantation Renal tubular dysfunction, in \u2424-thalassemia minor",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1164--1168",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Renal tubular regeneration, by bone marrow-derived cells after BMT, 5:E20 Renal ultrasonography, for diagnostic and interventional nephrology program",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "229--233",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Renovascular hypertension, atherosclerotic renal artery stenosis and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "858--863",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Residual renal function, graft and patient survival rates in preemptive renal transplant patients",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1275--1282",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Resistin, insulin resistance in renal disease and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "62--66",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Restenosis, access blood flow monitoring methods and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "539--545",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Retinal abnormalities, in mesangiocapillary glomerulonephritis type II",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "2",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Retrograde pyelography, acute renal failure after, 2:E6 Revascularization, of atherosclerotic renal artery stenosis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "858--863",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Reverse epidemiology, malnutrition-inflammation complex syndrome in dialysis and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "864--881",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "See Recombinant human erythropoietin Ribavirin for hepatitis C virus-related renal disease, 631-657 long-term therapy for HCV-positive renal transplant patients",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "184--192",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Risk adjustment, adapting Charlson Comorbidity Index for ESRD, 125-132 Risk factors for aortic atherosclerosis, in chronic renal failure, 277-285 for chronic kidney disease, KEEP program participants and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "4",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Rosiglitazone, glucose metabolism in nondiabetic uremic patients on CAPD and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "774--780",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Ruboxistaurin, for diabetic nephropathy with vascular complications",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "456--465",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Salivary secretion, in end-stage renal disease",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "722--728",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Sacroileitis, adult-onset tubulointerstitial nephritis and uveitis and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Severe acute respiratory syndrome Saxon's test, in long-term dialysis patient with ESRD",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Sars",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "722--728",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Screening, targeted for early kidney disease evaluation",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "22--35",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Segmental bioimpedance analysis, of ultrafiltration volume in peritoneal dialysis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "167--172",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Selection bias, reasons for nonenrollment in ARF cohort study",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "507--512",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Seroconversion of HBV, stage of chronic kidney disease and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1184--1192",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Sevelamer, and calcium acetate, bioavailability of ciprofloxacin and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1253--1259",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Severe acute respiratory syndrome (SARS) in dialysis patients, clinical presentation and outcome of, 1075-1081 in hemodialysis patient",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1069--1074",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Severity of illness, adapting Charlson Comorbidity Index for ESRD",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "125--132",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Shirmer's test, in long-term dialysis patient with ESRD",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "722--728",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Sickle cell disease, multiorgan failure during sickle cell crisis in sickle/\u2424\u03e9-thalassemia",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Signal transduction inhibition, for diabetic nephropathy with vascular complications",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "456--465",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Sirolimus-induced thrombotic microangiopathy, in renal transplant recipient",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1058--1068",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Sjogren's syndrome, with Gitelman's syndrome presenting with muscular paralysis",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "586--590",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Skin bleeding time, vs. in vitro closure time test for hemostasis assessment in HD patients",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "746--751",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Systemic lupus erythematosus Small bowel transplant, rejection-related diarrhea, hypochloremic metabolic alkalosis from",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Sle",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "See",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1283--1286",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Small-vessel vasculitis, diffuse alveolar hemorrhage, plasmapheresis for",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1149--1153",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "MPGN type I renal dysfunction prognosis and, 1131-1138 Socioeconomic status chronic kidney disease incidence and outcomes and, 677-684 dysregulation of immune balance resulting in glomerulonephritis, 575-581 receipt of renal replacement therapy and",
            "authors": [
                {
                    "first": "\u2423-Smooth Muscle",
                    "middle": [],
                    "last": "Actin",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "249--255",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Sodium-chloride cotransporter, Gitelman's syndrome with Sjogren's syndrome",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "586--590",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Sodium fractional excretion, renal tubular dysfunction in \u2424-thalassemia minor",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "1164--1168",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Southwestern histochemistry, detection of nuclear factor -B in IgA nephropathy",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "76--86",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Specimen handling, for microalbuminuria testing",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "245--248",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "ESRD and",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Spirituality",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "713--721",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Starvation, severe acidosis caused by, 5:E22 STAT6 gene polymorphisms, in children with minimal change nephrotic syndrome",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "271--276",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Steal syndrome, transposed basilic vein arteriovenous fistula and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "151--157",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Stem cell therapy autologous transplantation, for LCDD with renal involvement, 1154-1163 for renal disease",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "891--905",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Stenosis detection in AVFs, ultrasound dilution blood flow rate for, 331-341 renal artery atherosclerosis, medical management of",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "858--863",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "stent placement, predictive value of renal insufficiency in",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "926--935",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "restenosis, access blood flow monitoring methods and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "539--545",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Steroid resistance in focal segmental glomerulosclerosis, prednisone and LDL apheresis for, 1121-1130 in minimal change nephrotic syndrome, tacrolimus for, 5:E21 Stone disease, Tamm-Horsfall glycoprotein and",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "658--676",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "Brain injury, starvation ketoacidosis and, 5:E22 Branched-chain amino acids (BCAAs), in ESRD hemodialysis patients, 1212-1220 Branched-chain keto acid dehydrogenase (BCKAD), hemodialysis effects on, 1212-1220",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Embryonic stem cell research, ethical and legal issues, 891-905 End-of-life care, training in nephrology, need for, 813-820 Endothelial function, effect of ruboxistaurin in diabetic nephropathy, 456-465 Endothelial NO synthase gene polymorphism with basal peritoneal membrane function in uremia, 781-786 Endothelium, state in hemodialysis patients, circulating endothelial cells and, 704-712 Endovascular procedures, in diagnostic and interventional nephrology program, 229-233 End-stage renal disease (ESRD) analgesia in, 217-228 anemia in. See Anemia anterior ischemic optic neuropathy in children on chronic peritoneal dialysis, 5:E19 antihypertensive usage to reduce cardiovascular risk in dialysis patients, 1301-1304 atherosclerotic cardiovascular disease, in dialysis patients, lipoprotein(a) and, 108-116 comorbidity Charlson Comorbidity Index prediction of, 125-132 conversion from conventional to short daily hemodialysis and, 1020-1035 depression, peritonitis in long-term PD and, 350-354 dialysis costs in, 12-21 economic costs, S5:161-172 hemodialysis patient with SARS and SLE, 1069-1074 hospitalization frequency in, 972-981 hyperphosphatemia, lanthanum carbonate for, 96-107 hypertension treatment in incident HD and peritoneal dialysis, 1260-1269 impact of nephrology referral on outcome, 474-485 incidence, after renal replacement therapy for type 1 diabetes, 117-124 international comparisons, S5:173-181 kidney transplantation, S5:115-128 late referral to nephrologist, access to kidney transplantation and, 1043-1049 long-term peritoneal dialysis, gabapentin-induced hypoglycemia in, 6:E24 maintenance hemodialysis, hypercoagulability in, 797-805 markers of inflammation, proteolysis and apoptosis in, 1212-1220 need for end-of-life care training in nephrology, 813-820 outcomes, S5:103-114 patient characteristics, S5:61-74 pediatric, S5:129-140 peginterferon pharmacokinetics in, 631-657 prevalence and incidence, S5:47-60 prognostic value of cardiac markers in, 513-523 reduction of AGEs in long-term HD by on-line hemodialfiltration, 524-531 rehabilitation and quality of life, S5:151-160 renal replacement therapies in Finland, cost analysis of, Epid\u00e9miologie de l'Insuffisance Renale Chronique Terminale en Lorraine (EPIREL), impact of nephrology referral on ESRD outcome, 474-485 EPO. See Erythropoietin Epoetin. See Erythropoietin Epstein-Barr virus infection, adult-onset tubulointerstitial nephritis and uveitis and, 3:E11 Equilibrated normalized protein catabolic rate (enPCR), albumin and creatinine independent association with, 1200-1211 Equipment hepatitis B and C virus contamination in dialysis, 546-550 for quotidian hemodialysis, S1:66-70 Erythrocyte aldose reductase, in Japanese patients with type 2 diabetes, 943-951 Erythropoiesis, hemodialysis membrane composition effect on erythrocyte response, 551-560 Erythropoietin (EPO). See also Recombinant human erythropoietin anemia management in quotidian hemodialysis, S1:18-23 biocompatibility, hemodialysis membrane composition effect on erythrocyte response, 551-560 EPO-producing gastric carcinoma, in hemodialysis patient, 1:E1 heme iron polypeptide in HD patients and, 325-330 malnutrition-inflammation complex syndrome in dialysis and, 864-881 Escherichia coli, Tamm-Horsfall glycoprotein excretion and, 658-676 ESRD. See End-stage renal disease ESRD Clinical Performance Measures Project 2002 Annual Report adult in-center HD patients, S2:19-38 adult peritoneal dialysis, S2:39-48 background and project methods, S2:11-18 executive summary, S2:4-10 pediatric in-center hemodialysis, S2:48-56 Estimated glomerular filtration rate, kidney disease screening, 22-35 Ethanol injection therapy, for HD patients with renal hyper-Familial renal hypouricemia, with exercise-induced ARF, 1287-1292 Ferritin, serum heme iron polypeptide in HD patients and, 325-330 in vitro oxidative effects of ascorbic acid in uremia and, 158-166 Finland, cost analysis of renal replacement therapies in, 1228-1238 Fistula, mortality in elderly ESRD patients and, 1013-1019 Fistulography, vs. color Doppler ultrasound or ultrasound dilution method, 539-545 Flushing, cyclosporine-induced in minimal change ne-Kidney Disease Outcomes Quality Initiative. See K/DOQI Clinical Practice Guidelines Kidney Early Evaluation Program. See KEEP program",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "See Nonsteroidal anti-inflammatory drugs Nuclear factor -B, detection in IgA nephropathy, 76-86 Nursing issues, in quotidian hemodialysis, S1:56-60 Nutrient protein equivalent of total nitrogen appearance, quotidian hemodialysis and, S1:30-35 Nutrineal, long-term study in CAPD, 173-183 Nutrition albumin and creatinine independent association with, 1200-1211 dietary glycotoxins, circulating AGEs in renal failure and, 532-538 quotidian hemodialysis and, S1:30-35Obesity chronic kidney disease risk and, S4:34-S4:41 KEEP program participants, S4:16-S4:27, S4:28-S4:33 Ofloxacin, pharmacokinetics during CVVH, 310-314 O-Glycan structure, of IgA1 produced by tonsillar lymphocytes in IgA nephrology, 486-496 On-line hemodialfiltration, reduction of advanced glycation end products in long-term HD, 524-531 Operating costs, comparison of conventional vs. home quotidian hemodialysis, S1:49-55 Opioids, for pain in hemodialysis, 1239-1247 Organ allocation, for kidney transplantation, 882-890 Osteoblasts, after parathyroidectomy for secondary hyperparathyroidism, 729-738 Osteoclasts, after parathyroidectomy for secondary hyperparathyroidism, 729-738 Osteomalacia, K/DOQI Clinical Practice Guidelines, S3: 124-125 Osteoporosis, intestinal calcium absorption in hypercalciuric stone-forming women and, 1177-1183 Osteoprotegerin progression of vascular calcification in long-term HD and, 303-309 serum leptin in renal osteodystrophy and, 1036-1042 Outcome conversion from conventional to daily HD for ESRD patients, 1020-1035 dialysis costs in ESRD and, 12-21 of dialysis with malnutrition-inflammation complex, 864-881 ESRD, USRDS annual report on, S5:103-114 long-term of kidney transplantation for amyloidosis, 370-375 of severe acute respiratory syndrome in dialysis, Oxaloabacter formigenes, nephrolithiasis in cystic fibrosis and, 1-11 Oxaluria, nephrolithiasis in cystic fibrosis and, 1-11 Oxidative stress during hemodialysis, ascorbic acid effects on, 158-166 in maintenance HD patients with hypoalbuminemia, 286-294 Pain in hemodialysis patients, 1239-1247 quality of life in ESRD and, 713-721 Pamidronate, PTH secretion in postmenopausal HD patients with secondary hyperparathyroidism, 1221-1227 Pancreas transplantation, quality of life after, 431-445 Pancreatic function insufficient, with rapidly progressive renal failure, 842-845 in peritoneal dialysis patients, 787-796 Parathyroidectomy in CKD, K/DOQI Clinical Practice Guidelines, S3:127-129 for secondary hyperparathyroidism, bone remodeling changes after, 729-738 vs. percutaneous ethanol injection therapy for renal hyperparathyroidism in HD patients, 739-745 Parathyroid hormone (PTH). See also Hyperparathyroidism lanthanum carbonate effects on, 96-107 secretion, pamidronate effects in postmenopausal HD patients with secondary hyperparathyroidism, 1221-1227 serum leptin in renal osteodystrophy and, 1036-1042 Patient education, time to dialysis and, 693-703 PD. See Peritoneal dialysis Pediatric patients. See Children Peginterferon, pharmacokinetics in ESRD, 631-657 Pentoxifylline, urinary NAG in type 2 diabetes and, 264-270 Percutaneous angioplasty, of atherosclerotic renal artery stenosis, 851-857, 858-863 Percutaneous ethanol injection therapy, for HD patients with renal hyperparathyroidism, 739-745 Stress oxidative during hemodialysis, ascorbic acid effects on, 158-166 in maintenance HD patients with hypoalbuminemia, 286-294 severe acidosis caused by, 5:E22 Stroke, hypertensive pregnancy and, 982-989 Strontium absorption test, intestinal calcium absorption in hypercalciuric stone-forming women and, 1177-1183 Subarachnoid hemorrhages, in vasculitis, 582-585 Surgical technique, in predicting successful AVF maturation, 1000-1012 Surveillance, access, in vivo validation of glucose pump test for access flow, 752-760 Survival in ESRD, Charlson Comorbidity Index prediction of, 125-132 light chain deposition disease with renal involvement, 1154-1163 residual renal function in preemptive kidney transplantation and, 1275-1282 Symptoms, quality of life in ESRD and, 713-721 Systemic lupus erythematosus de novo after cadaveric renal transplantation, 3:E15 hemodialysis patient with ESRD and SARS, 1069-1074 Tacrolimus in steroid-and cyclophosphamide-resistant MCNS, 5:E21 thrombotic microangiopathy after renal transplantation and, 1058-1068 Tamm-Horsfall glycoprotein biology and clinical relevance, 658-676 uromodulin gene mutations, renal manifestations of, E8 Terminal illness, analgesia in end-stage renal disease, 217-228 Thalassemia, multiorgan failure during sickle cell crisis in sickle/\u2424\u03e9-thalassemia, E4 \u2424-Thalassemia minor, renal tubular dysfunction in, 1164-1168 T helper cell subsets, hygiene and socioeconomic dysregulation, glomerulonephritis development and, 575-581 Thiazide, for Gitelman's syndrome with Sjogren's syndrome, 586-590 Thin basement membrane disease, nephrology core curriculum, 1305-1317 Thromboembolism, hypertensive pregnancy and, 982-989 Thrombolytics, for acute coronary syndromes in renal patients, 446-455 Thrombosis, prediction in AVFs, ultrasound dilution blood flow rate for, 331-341 Thrombotic microangioplasty, after renal transplantation, 1058-1068 Thrombotic thrombocytopenic purpura, thrombotic microangiopathy after renal transplantation and, 1058-1068 Time to dialysis, predialysis psychoeducational intervention and coping styles, 693-703 Time trade-off, quality of life on quotidian hemodialysis, S1: 36-41 Tonsillar lymphocytes, IGA1, O-glycan structure in IgA nephrology, 486-496 Training, nurse, in quotidian hemodialysis, S1:56-60 Tramadol, in end-stage renal disease, 217-228 Trandolapril, with verapamil vs. amlodipine in nondiabetic nephropathy, 67-75 Transesophageal echocardiography, of aortic atherosclerosis in CRF, 277-285 Transposed basilic vein arteriovenous fistula, vascular access outcomes, 151-157 Triple-lumen catheters, vs. dual-lumen catheters for hemodialysis and apheresis, 315-324 Tropins, prognostic value in ESRD, 513-523 Tuberous sclerosis complex, nephrology core curriculum, 1305-1317 Tubulointerstitial injury, urinary NAG excretion in type 2 diabetes, pentoxifylline effects on, 264-270 Tubulointerstitial nephritis Gitelman's syndrome with Sjogren's syndrome, 586-590 Tamm-Horsfall glycoprotein and, 658-676 and uveitis, associated with sacroileitis and EBV infection, 3:E11 Tumor necrosis factor-\u2423 effect of malnutrition-inflammation complex on EPO hyporesponsiveness in maintenance HD, 761-773 in ESRD hemodialysis patients, 1212-1220 in peritoneal dialysis patients, 787-796 urinary albumin excretion in type 2 diabetes mellitus and, 53-61 Ubiquitin, in ESRD hemodialysis patients, 1212-1220 Ubiquitin-proteasome pathway, hemodialysis effects on, 1212-1220 Ultrafiltration volume measurement, by segmental bioimpedance analysis, 167-172 Ultrasonography for diagnostic and interventional nephrology program, 229-233 dilution method access blood flow in AVFs, 331-341 vs. color Doppler ultrasound or fistulography, 539-545 United States Renal Data System (USRDS) thrombotic microangiopathy after renal transplantation and, 1058-1068 UNOS Point System, for cadaver kidney allocation, 882-890 URAT1 gene, exercise-induced ARF with familial renal hypouricemia, 1287-1292 Urea filtration rate/volume, quotidian hemodialysis and, S1: 42-48 Urea kinetics, quotidian hemodialysis and, S1:42-48 Uremia dialysis membrane composition effect on erythrocyte response, 551-560 nondiabetic, rosiglitazone effect on insulin resistance in CAPD, 774-780 pamidronate for in postmenopausal HD patients with secondary hyperparathyroidism, 1221-1227 resistin blood levels in, 62-66 Urinary biomarker, for tubular injury in ARF, 497-506 Urinary calculi, in cystic fibrosis, 1-11 Urinary proteins, Tamm-Horsfall glycoprotein, 658-676 Urine volume, nephrolithiasis in cystic fibrosis and, 1-11 Urolithiasis in cystic fibrosis, 1-11 Tamm-Horsfall glycoprotein and, 658-676 Uromodulin gene mutations, renal manifestations of, 2:E8 Tamm-Horsfall glycoprotein and, 658-676 USRDS. See United States Renal Data System Vascular access. See also specific vascular access methods blood flow monitoring by ultrasound dilution blood method, for AVFs, 331-341 ultrasound dilution vs. color Doppler ultrasound or fistulography, 539-545 in vivo validation of glucose pump test for, 752-760 conversion from conventional hemodialysis to daily hemodialysis for ESRD patients, 1020-1035 in London Daily/Nocturnal Hemodialysis Study, S1:5-12 outcome, transposed basilic vein arteriovenous fistula and, 151-157 patency, transposed basilic vein arteriovenous fistula and, 151-157 predictors of successful AVF maturation, 1000-1012 in quotidian hemodialysis, S1:56-60 recirculation, ultrasound dilution blood method for AVFs, 331-341 Vascular calcification, in long-term HD, serum osteoprotegerin and, 303-309 Vascular disease, progression of renal insufficiency in type 2 diabetes mellitus, 936-942 Vascular endothelial growth factor, urinary excretion, MGN clinical course and, 1139-1148 Vasculitis with glomerulonephritis, effects of doxycycline on, 366-380 subarachnoid hemorrhages in, 582-585 Verapamil, with trandolapril, proteinuria in nondiabetic nephropathy and, 67-75 Viral replication, HBV and HCV in renal allograft, evaluation of, 193-201 Visual impairment, in mesangiocapillary glomerulonephritis type II, 2:E3 Vitamin C, effect on oxidative stress parameters in HD, 158-166 Vitamin D insufficiency/deficiency, treatment of, S3:84-89 metabolic alterations in CKD, S3:29-44 therapy for CKD patients, S3:89-92 for dialysis patients, S3:92-98 Water treatment, for quotidian hemodialysis, S1:66-70 White blood cell count, chronic kidney disease and, 256-263 Women chronic kidney disease risk and, S4:34-S4:41 hypercalciuric stone-forming, intestinal calcium absorption and BMD in, 1177-1183 postmenopausal, pamidronate for secondary hyperparathyroidism in, 1221-1227 quality of life in ESRD and, 713-721 thrombotic microangiopathy after renal transplantation and, 1058-1068 Xerophthalmia, in end-stage renal disease, 722-728 Xerostomia, in end-stage renal disease, 722-728 Zinc excretion, renal tubular dysfunction in \u2424-thalassemia minor, 1164-1168",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "adequacy of, S1:42-48 anemia management, S1:18-23 calcium and phosphate balance in, S1:24-29 conventional vs. home, cost comparison of, S1:49-55 equipment and water treatment considerations, S1:66-70 nursing issues, S1:56-60 nutritional status and, S1:30-35 patient quality of life, S1:36-41 volume control and blood pressure management in, S1: 13-17 ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}